Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial.
Department of Psychiatry, Fujita Health University School of Medicine.
Department of Psychiatry, Fujita Health University School of Medicine; Department of Psychiatry, Okehazama Hospital, Toyoake.
Department of Psychiatry, Okehazama Hospital, Toyoake.
Department of Psychiatry, Jindai Clinic, Nagoya.
Department of Psychiatry, Toyota Memorial Hospital.
Department of Psychiatry, Jindai Hospital, Toyota, Aichi.
Department of Psychiatry, Holy Cross Hospital, Toki, Gifu, Japan.
- Published Article
Neuropsychiatric Disease and Treatment
Dove Medical Press
- Publication Date
Jan 01, 2017
Our results suggest that escitalopram and paroxetine controlled release had similar efficacy and safety profiles in patients with MDD. One of the primary limitations of this study is the small sample size.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/28123299